Navigation Links
Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18

a in situ (AIS)), cervical pre-cancers (cervical intraepithelial neoplasia (CIN) grade 2), vulvar pre-cancers (vulvar intraepithelial neoplasia (VIN) 2/3) and vaginal pre-cancers (vaginal intraepithelial neoplasia (VaIN) 2/3), and for the prevention of genital warts and low-grade cervical lesions (CIN 1) caused by HPV types 6, 11, 16 and 18. GARDASIL is contraindicated in individuals who are hypersensitive to the active substances or to any of the excipients of the vaccine.

High grade vulvar and vaginal lesions indicators for possible development of cancer

The studies used for this analysis combine findings from one phase II study and two phase III studies - Protocol 007, Protocol 013 (FUTURE I) and Protocol 015 (FUTURE II), respectively. All three studies were double-blind, placebo-controlled randomized studies and were conducted at 157 sites in 24 countries. More than 18,000 women participated in the three trials and were between the ages of 16 to 26 at the time of enrollment. They received three doses of either GARDASIL or placebo at day one, month two and month six. The combined analysis evaluated the impact of GARDASIL on the incidence of high-grade vulvar and vaginal pre-cancers (VIN 2/3 and VaIN 2/3), common precursors to vulvar and vaginal cancers in younger women, caused by HPV types 16 and 18.

In the per-protocol population of this combined analysis, GARDASIL was 100 percent effective in preventing HPV 16- and 18-related VIN 2/3 and VaIN 2/3 in women who were not exposed to the relevant HPV types until at least one month after completing the vaccination series; no cases were observed in the vaccine group (n=7,811) compared to 15 cases in the placebo group (n=7,785).

In the unrestricted population of this combined analysis, GARDASIL was 97 percent effective in preventing HPV 16- and 18-related VIN 2/3 and VaIN 2/3 in women who may have been exposed to the relevant HPV types before completing the vaccination series; one case was o
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:10/31/2014)... AUSTIN, Texas , Oct. 31, 2014 /PRNewswire/ ... 3D holographic visualization technologies announced today a strategic ... industry leader in high-end 3D anatomy and biomedical ... the medical and medical education markets.  Zygote maintains ... anatomy and biomedical models and has pioneered development ...
(Date:10/31/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP)( ... the development of oral drug delivery systems, announces ... to discuss the clinical results from its Phase ... oral insulin capsules, to treat type 1 diabetes ... Eastern time. Shareholders and other interested ...
(Date:10/31/2014)...  Zacks.com announces the list of stocks featured in the Analyst ... news and events impacting stocks and the financial markets. Stocks recently ... - Free Report ), Celgene (Nasdaq: CELG - ... Free Report ), Market Vectors Biotech ETF (AMEX: BBH ... XBI - Free Report ). Today, ...
Breaking Medicine Technology:Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7
... May 3, 2012 Cardinal Health today reported a 3 ... and a 6 percent increase in non-GAAP operating earnings to ... in non-GAAP diluted earnings per share (EPS) from continuing operations ... solid quarter of revenue growth for both of our business ...
...  Cara Therapeutics, Inc. and Chong Kun Dang Pharmaceutical Corporation ... a licensing agreement that provides CKD Pharm with the ... drug candidate, CR845, in the Republic of Korea.  Under ... up-front payment, including an equity investment, and is eligible ...
Cached Medicine Technology:Cardinal Health Reports Third-Quarter Results 2Cardinal Health Reports Third-Quarter Results 3Cardinal Health Reports Third-Quarter Results 4Cardinal Health Reports Third-Quarter Results 5Cardinal Health Reports Third-Quarter Results 6Cardinal Health Reports Third-Quarter Results 7Cardinal Health Reports Third-Quarter Results 8Cardinal Health Reports Third-Quarter Results 9Cardinal Health Reports Third-Quarter Results 10Cardinal Health Reports Third-Quarter Results 11Cardinal Health Reports Third-Quarter Results 12Cardinal Health Reports Third-Quarter Results 13Cardinal Health Reports Third-Quarter Results 14Cardinal Health Reports Third-Quarter Results 15Cardinal Health Reports Third-Quarter Results 16Cardinal Health Reports Third-Quarter Results 17Cardinal Health Reports Third-Quarter Results 18Cardinal Health Reports Third-Quarter Results 19Cardinal Health Reports Third-Quarter Results 20Cardinal Health Reports Third-Quarter Results 21Cardinal Health Reports Third-Quarter Results 22Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market 2Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market 3
(Date:10/31/2014)... (PRWEB) October 31, 2014 Urban Hydroponics, ... “Company”) today announced it has signed a Binding Letter ... in the urban cultivation sector - Urban Cultivator Inc. ... Lights”), and W3 Metal Inc. (“W3 Metal” and together ... Companies”). Pursuant to the LOI and an earlier ...
(Date:10/31/2014)... 31, 2014 Triple Board Certified surgeon ... restoration services to transform the appearance of military veteran ... Academy of Facial Plastic and Reconstruction Surgery (AAFPRS) Faces ... restore the facial hair Jones lost during an IED ... pro-bono hair restoration procedure, valued around $16,000, took Dr. ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Med-Care Diabetic ... on the highest principles of patient care and service, ... leading health and wellness website, to provide an online ... diabetes. , The Diabetes Health Center will provide ... for those living with diabetes. Content will feature advice ...
(Date:10/31/2014)... Dennis Thompson HealthDay Reporter ... full-court press involving all public health tactics known to ... current West African epidemic, a new study reports. ... in a hygienic way, immediately isolating new patients, tracing ... protection for health care workers -- can stop the ...
(Date:10/31/2014)... Alan Mozes HealthDay Reporter ... the world of 21st-century medicine, organ transplantation is nothing new. ... by the first liver transplant in 1963 and the first ... managed the transplantation of a patient,s entire face. One ... human eye. But if one team of U.S. scientists has ...
Breaking Medicine News(10 mins):Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5Health News:Miami Hair Restoration Specialist Transforms Wounded Soldier 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 3Health News:4 Steps Could Quell Ebola in West Africa, Researchers Say 2Health News:4 Steps Could Quell Ebola in West Africa, Researchers Say 3Health News:Scientists Set Their Sights on First Whole-Eye Transplant 2Health News:Scientists Set Their Sights on First Whole-Eye Transplant 3
... is available in French . Montreal, November ... the marketplace, thanks to a new partnership between Gestion ... a privately owned technology company based in Montreal. ... and its affiliated institutions, and CSI have announced the ...
... Nov. 25, 2009 Physicians at UT Southwestern Medical Center ... breathing in patients with upper spinal-cord injuries or other diseases ... University Hospital St. Paul is only one of only ... country currently equipped to implant the device, called the NeuRx ...
... success for patients with liver lesions, researchers find , ... cetuximab to neoadjuvant chemotherapy can shrink tumors and boost ... with inoperable metastatic liver lesions, new research suggests. ... the body in more than half of patients with ...
... Two experts offer waistline-friendly ways to enjoy festive feasting , ... five-week holiday smorgasbord from Thanksgiving to New Year,s, but are ... off come Jan. 1, help is at hand. , It,s ... make it to 2010 weighing the same as you ...
... ... natural treatments to complement conventional methods. , ... Burnaby, BC (Vocus) November 25, 2009 -- While surgery, chemotherapy ... turn to alternative medicine to help them cope with the side effects of conventional ...
... ... a new market research report is available in its ... (2nd Edition) , http://www.reportlinker.com/p0165301/The-Market-for-Anti-ageing-Foods-(2nd-Edition ).html , ... a fast pace with growth outstripping that of conventional ...
Cached Medicine News:Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3Health News:Holistic and Western Medicine Combined Can Fight Cancer 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 3Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 4Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 5Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 6Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 7
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
VACUETTE PaediatricMulti-Sample Needle...
... Blood Collection Needles are preominantly used for ... single-use. The colour of the needle protective ... needle gauges. For example, yellow symbolises the ... 21 G (0.80 mm) and black 22 ...
This is adapted to microplate or card....
Medicine Products: